ApprovalTrail

Approval · Notice of Compliance 19997 · 2017

IMRESTOR: Notice of Compliance 19997

Issued November 1, 2017

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
19997
Date
November 1, 2017
Company
Elanco Canada LimitedGuelph, Ontario, Canada
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Merger -- buyout

Products in this notice

BrandDINStatus today
IMRESTOR02452820Dormant

Medicinal ingredients